• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Predictors of Unfavorable Outcomes in COVID-19-Related Sepsis: A Prospective Cohort Study.新冠病毒相关脓毒症不良结局的预测因素:一项前瞻性队列研究。
Viruses. 2025 Mar 21;17(4):455. doi: 10.3390/v17040455.
2
Accuracy of routine laboratory tests to predict mortality and deterioration to severe or critical COVID-19 in people with SARS-CoV-2.常规实验室检测对预测 SARS-CoV-2 感染者死亡和病情恶化为重症或危重症 COVID-19 的准确性。
Cochrane Database Syst Rev. 2024 Aug 6;8(8):CD015050. doi: 10.1002/14651858.CD015050.pub2.
3
Systemic Inflammatory Response Syndrome全身炎症反应综合征
4
Tomographic features of lung damage associate with D-Dimer levels and further clinical outcome in patients with acute respiratory distress syndrome due to COVID-19.新型冠状病毒肺炎所致急性呼吸窘迫综合征患者肺部损伤的断层扫描特征与D-二聚体水平及进一步临床结局的相关性
BMC Pulm Med. 2025 Feb 6;25(1):65. doi: 10.1186/s12890-025-03531-1.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Liver Scores in the Prognostication of COVID-19 Patients.肝脏评分在COVID-19患者预后评估中的作用
Viruses. 2025 Mar 19;17(3):444. doi: 10.3390/v17030444.
7
Sex-based differences in inflammatory predictors of outcomes in patients undergoing mechanical thrombectomy: an inverse probability weighting analysis.接受机械取栓治疗患者结局的炎症预测指标中的性别差异:逆概率加权分析
Ther Adv Neurol Disord. 2025 Jun 21;18:17562864251345719. doi: 10.1177/17562864251345719. eCollection 2025.
8
Automated monitoring compared to standard care for the early detection of sepsis in critically ill patients.与标准护理相比,自动监测用于危重症患者脓毒症的早期检测
Cochrane Database Syst Rev. 2018 Jun 25;6(6):CD012404. doi: 10.1002/14651858.CD012404.pub2.
9
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
10
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.用于治疗 COVID-19 的 SARS-CoV-2 中和单克隆抗体。
Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2.

引用本文的文献

1
Systemic inflammatory indices and age-dependent severity in acute appendicitis: a retrospective cohort study.急性阑尾炎的全身炎症指标与年龄相关的严重程度:一项回顾性队列研究
Front Immunol. 2025 Jul 15;16:1620459. doi: 10.3389/fimmu.2025.1620459. eCollection 2025.

本文引用的文献

1
Predicting Mortality in Sepsis: The Role of Dynamic Biomarker Changes and Clinical Scores-A Retrospective Cohort Study.预测脓毒症患者的死亡率:动态生物标志物变化及临床评分的作用——一项回顾性队列研究
Diagnostics (Basel). 2024 Sep 6;14(17):1973. doi: 10.3390/diagnostics14171973.
2
Charlson comorbidity index and the severity of community-acquired pneumonia caused by SARS-CoV-2: A retrospective analysis.基于 Charlson 共病指数分析 SARS-CoV-2 引起的社区获得性肺炎的严重程度:一项回顾性分析。
Dent Med Probl. 2024 Mar-Apr;61(2):173-179. doi: 10.17219/dmp/166666.
3
Immune Modulation in Sepsis, ARDS, and Covid-19 - The Road Traveled and the Road Ahead.脓毒症、ARDS 和 COVID-19 中的免疫调节:走过的路和前方的路。
NEJM Evid. 2022 Nov;1(11):EVIDra2200118. doi: 10.1056/EVIDra2200118. Epub 2022 Oct 25.
4
Radiological Findings as Predictors of COVID-19 Lung Sequelae: A Systematic Review and Meta-analysis.影像学表现对 COVID-19 肺部后遗症的预测价值:系统评价和荟萃分析。
Acad Radiol. 2023 Dec;30(12):3076-3085. doi: 10.1016/j.acra.2023.06.002. Epub 2023 Jun 6.
5
C-reactive protein and procalcitonin during course of sepsis and septic shock.C 反应蛋白和降钙素原在脓毒症和脓毒性休克病程中的变化。
Ir J Med Sci. 2024 Feb;193(1):457-468. doi: 10.1007/s11845-023-03385-8. Epub 2023 May 19.
6
D-Dimer Levels and the Disseminated Intravascular Coagulation Score to Predict Severity and Outcomes in Sepsis or Septic Shock.D-二聚体水平和弥散性血管内凝血评分预测脓毒症或脓毒性休克的严重程度和结局。
Clin Lab. 2023 May 1;69(5). doi: 10.7754/Clin.Lab.2022.221015.
7
Selected Predictors of COVID-19 Mortality in the Hospitalised Patient Population in a Single-Centre Study in Poland.波兰一项单中心研究中住院患者群体中 COVID-19 死亡率的选定预测因素。
Healthcare (Basel). 2023 Mar 1;11(5):719. doi: 10.3390/healthcare11050719.
8
Meeting the Challenges of Sepsis in Severe Coronavirus Disease 2019: A Call to Arms.应对2019年重症冠状病毒病中的脓毒症挑战:战斗的号角
Open Forum Infect Dis. 2022 Dec 1;10(1):ofac645. doi: 10.1093/ofid/ofac645. eCollection 2023 Jan.
9
Evaluation of the Charlson Comorbidity Index and Laboratory Parameters as Independent Early Mortality Predictors in Covid 19 Patients.评估Charlson合并症指数和实验室参数作为新冠病毒19患者早期死亡率的独立预测指标
Int J Gen Med. 2022 Jul 27;15:6301-6307. doi: 10.2147/IJGM.S374246. eCollection 2022.
10
Does the Charlson comorbidity index help predict the risk of death in COVID-19 patients?查尔森合并症指数有助于预测新冠肺炎患者的死亡风险吗?
North Clin Istanb. 2022 Apr 12;9(2):117-121. doi: 10.14744/nci.2022.33349. eCollection 2022.

新冠病毒相关脓毒症不良结局的预测因素:一项前瞻性队列研究。

Predictors of Unfavorable Outcomes in COVID-19-Related Sepsis: A Prospective Cohort Study.

作者信息

Mateescu Diana-Maria, Cotet Ioana, Guse Cristina, Prodan-Barbulescu Catalin, Varga Norberth-Istvan, Iurciuc Stela, Craciun Maria-Laura, Ilie Adrian-Cosmin, Enache Alexandra

机构信息

Doctoral School, Department of General Medicine, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.

Cardiology Department, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania.

出版信息

Viruses. 2025 Mar 21;17(4):455. doi: 10.3390/v17040455.

DOI:10.3390/v17040455
PMID:40284898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12031614/
Abstract

Sepsis is a leading cause of mortality in critically ill patients, arising from a dysregulated immune response to infection. While traditionally associated with bacterial pathogens, severe COVID-19 can induce a sepsis-like syndrome, characterized by systemic inflammation, endothelial dysfunction, and coagulation abnormalities. This study aimed to assess the prognostic value of age, inflammatory markers, coagulation dysfunction, comorbidity burden, and lung involvement on computer tomography (CT) scans in predicting poor outcomes. We conducted a prospective cohort study including 163 patients diagnosed with COVID-19-related sepsis. Univariate and multivariable logistic regression analyses were performed to identify the independent predictors of unfavorable outcomes. Higher D-dimer (OR: 1.417, = 0.020) and C-reactive protein (CRP) levels (OR: 1.010, = 0.027) were independently associated with poor outcomes. A greater than 50% lung involvement on CT (OR: 1.774, = 0.025) was also a significant predictor. The Charleson Comorbidity Index (CCI) showed a strong trend toward significance ( = 0.065), while age lost statistical significance after adjusting for comorbidities. Our findings suggest that D-dimers, CRP, and lung involvement on CT are key independent predictors of poor outcomes in COVID-19-related sepsis. These results emphasize the importance of inflammatory and coagulation markers, alongside comorbidity burden, in early risk assessment. Further prospective studies are warranted to refine predictive models for severe COVID-19 cases complicated by sepsis.

摘要

脓毒症是重症患者死亡的主要原因,源于对感染的免疫反应失调。虽然传统上与细菌病原体有关,但重症新型冠状病毒肺炎(COVID-19)可诱发类似脓毒症的综合征,其特征为全身炎症、内皮功能障碍和凝血异常。本研究旨在评估年龄、炎症标志物、凝血功能障碍、合并症负担以及计算机断层扫描(CT)肺部受累情况对预测不良结局的预后价值。我们进行了一项前瞻性队列研究,纳入了163例诊断为COVID-19相关脓毒症的患者。进行单因素和多因素逻辑回归分析以确定不良结局的独立预测因素。较高的D-二聚体(比值比:1.417,P = 0.020)和C反应蛋白(CRP)水平(比值比:1.010,P = 0.027)与不良结局独立相关。CT显示肺部受累超过50%(比值比:1.774,P = 0.025)也是一个显著的预测因素。查尔森合并症指数(CCI)显示出强烈的显著趋势(P = 0.065),而在调整合并症后年龄失去统计学意义。我们的研究结果表明,D-二聚体、CRP和CT肺部受累情况是COVID-19相关脓毒症不良结局的关键独立预测因素。这些结果强调了炎症和凝血标志物以及合并症负担在早期风险评估中的重要性。有必要进行进一步的前瞻性研究以完善重症COVID-19合并脓毒症病例的预测模型。